5P50CA058187/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2010	2
2012	1
2013	1
2025	0

Page 1

Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Linger RM, Keating AK, Earp HS, Graham DK. Linger RM, et al. Expert Opin Ther Targets. 2010 Oct;14(10):1073-90. doi: 10.1517/14728222.2010.515980. Expert Opin Ther Targets. 2010. PMID: 20809868 Free PMC article. Review.

Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.

Lee-Sherick AB, Linger RM, Gore L, Keating AK, Graham DK. Lee-Sherick AB, et al. Br J Haematol. 2010 Nov;151(4):295-311. doi: 10.1111/j.1365-2141.2010.08282.x. Epub 2010 Aug 31. Br J Haematol. 2010. PMID: 20813012 Free PMC article. Review.

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.

Linger RM, Cohen RA, Cummings CT, Sather S, Migdall-Wilson J, Middleton DH, Lu X, Barón AE, Franklin WA, Merrick DT, Jedlicka P, DeRyckere D, Heasley LE, Graham DK. Linger RM, et al. Oncogene. 2013 Jul 18;32(29):3420-31. doi: 10.1038/onc.2012.355. Epub 2012 Aug 13. Oncogene. 2013. PMID: 22890323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year